With over 200,000 molecular genetic tests conducted each year across all specialties, the Cerba laboratory is a major partner in the screening and diagnosis of somatic diseases.
Cerba is recognized for its panel of medical and technical expertise and its involvement in healthcare offerings at the local, national, and international levels, with a presence in over 40 countries.
There are many uncertainties, it is crucial to provide treatment as soon as possible, making it often a race against time
First the strength of the patients themselves.
The strength of their families as well.
And the strength of healthcare professionals who fight alongside them.
and put ourselves at the service of those who provide care : to accelerate diagnosis, to facilitate decision-making, treatment choice and monitoring. We achieve this by offering clinicians innovative analysis solutions that combine genetics, molecular biology, and digital tools
Today, precision genomic medicine offers new therapeutic solutions, personalized according to the genetic profile of the patient's tumor. In parallel, the development of digital tools represents a tremendous lever for transforming prescription tools and accelerating diagnosis.
Cerba Oncology is committed alongside healthcare professionals and provides them with innovative and efficient examination solutions, enabling them to fight diseases more effectively.
Our analysis system combines an extensive catalog with a high-throughput NGS sequencing platform to reduce the time between initial analysis and patient treatment initiation. It thus addresses the needs of precision medicine and the growing development of targeted therapies.
As pioneers of innovation, we develop cutting-edge tests that optimize the patient care journey, and we provide new tools for molecular diagnostics.
To remove all uncertainties around the diagnosis, our expert biologists assist you throughout the entire process, from the selection and conduct of an examination to the interpretation of its results
For a swift and efficient molecular diagnosis, logistics is key. We work with an accredited partner, BioLogistic, who ensures daily collection of your requests, in compliance with pre-analytical conditions.
To further facilitate and expedite the diagnostic process, we are developing new 100% digital prescription tools for you. As a client, our new connected prescription platform will provide you with real-time access to your results, anytime and anywhere, to help your decision-making process.